865 related articles for article (PubMed ID: 11677936)
41. Effects of surgical treatment and adjuvant chemotherapy studied by the depth of penetration in gastric cancer patients undergoing curative gastrectomy.
Yasuna O; Hatayama Y; Yamaura Y; Ogiwara M; Koike H; Nakamura K; Kusano M
Surgery; 1984 Jan; 95(1):78-84. PubMed ID: 6691187
[TBL] [Abstract][Full Text] [Related]
42. [Disciplinarian of lymph node metastasis and effect of paraaortic lymph nodes dissection on clinical outcomes in advanced gastric carcinoma].
Zhan WH; Han FH; He YL; Li YM; Zheng ZQ; Peng JS; Cai SR; Ma JP
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jan; 9(1):17-22. PubMed ID: 16437364
[TBL] [Abstract][Full Text] [Related]
43. Survival analysis after surgical treatment of gastric cancer: review of 121 cases.
Nazli O; Derici H; Tansug T; Yaman I; Bozdag AD; Isgüder AS; Bölükbasi H
Hepatogastroenterology; 2007 Mar; 54(74):625-9. PubMed ID: 17523337
[TBL] [Abstract][Full Text] [Related]
44. [Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].
Han JQ; Liu Q; Liang RX; Qu FS; Yan TX; Sun YH; Li XQ
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):470-3. PubMed ID: 17974287
[TBL] [Abstract][Full Text] [Related]
45. [Stomach cancer: 10 years experiences with surgical treatment and possibilities for improving the prognosis].
Spataro V; Genoni M; Maurer C; Müller W
Helv Chir Acta; 1993 Mar; 59(4):589-95. PubMed ID: 8473176
[TBL] [Abstract][Full Text] [Related]
46. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01.
Smith RE; Colangelo L; Wieand HS; Begovic M; Wolmark N
J Natl Cancer Inst; 2004 Aug; 96(15):1128-32. PubMed ID: 15292384
[TBL] [Abstract][Full Text] [Related]
47. [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent S-1-based neoadjuvant/adjuvant chemotherapy].
Sakurai Y; Kamoshida S; Furuta S; Sunagawa R; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
Gan To Kagaku Ryoho; 2008 Jul; 35(7):1147-55. PubMed ID: 18633253
[TBL] [Abstract][Full Text] [Related]
48. Overview of adjuvant therapy for resected gastric cancer: differences in Japan and the United States.
Ohtsu A; Sasako M
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S101-4. PubMed ID: 16399444
[TBL] [Abstract][Full Text] [Related]
49. Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy.
Persiani R; D'Ugo D; Rausei S; Sermoneta D; Barone C; Pozzo C; Ricci R; La Torre G; Picciocchi A
J Surg Oncol; 2005 Mar; 89(4):227-36; discussion 237-8. PubMed ID: 15726615
[TBL] [Abstract][Full Text] [Related]
50. Proposal to subclassify stage IV gastric cancer into IVA, IVB, and IVM.
An JY; Ha TK; Noh JH; Sohn TS; Kim S
Arch Surg; 2009 Jan; 144(1):38-45; discussion 45. PubMed ID: 19153323
[TBL] [Abstract][Full Text] [Related]
51. Significant prognostic factors in patients with node-negative gastric cancer.
Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
Int Surg; 1999; 84(4):331-6. PubMed ID: 10667813
[TBL] [Abstract][Full Text] [Related]
52. [Utilization of multimodal therapy concepts in stomach carcinoma in Germany].
Bösing NM; Heise JW; Röher HD
Zentralbl Chir; 2000; 125(4):341-7. PubMed ID: 10829314
[TBL] [Abstract][Full Text] [Related]
53. Preoperative intraperitoneal chemotherapy for patients with serosa-infiltrating gastric cancer.
Yano M; Yasuda T; Fujiwara Y; Takiguchi S; Miyata H; Monden M
J Surg Oncol; 2004 Oct; 88(1):39-43. PubMed ID: 15384086
[TBL] [Abstract][Full Text] [Related]
54. Clinicopathologic characteristics and prognosis for young gastric adenocarcinoma patients after curative resection.
Lai JF; Kim S; Li C; Oh SJ; Hyung WJ; Choi WH; Choi SH; Wang LB; Noh SH
Ann Surg Oncol; 2008 May; 15(5):1464-9. PubMed ID: 18340495
[TBL] [Abstract][Full Text] [Related]
55. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
56. Analysis of survival factors in patients with advanced-stage gastric adenocarcinoma.
Alici S; Kaya S; Izmirli M; Tuncer I; Doğan E; Ozbek H; Sayarlioglu H
Med Sci Monit; 2006 May; 12(5):CR221-9. PubMed ID: 16641880
[TBL] [Abstract][Full Text] [Related]
57. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.
Yano M; Shiozaki H; Inoue M; Tamura S; Doki Y; Yasuda T; Fujiwara Y; Tsujinaka T; Monden M
World J Surg; 2002 Sep; 26(9):1155-9. PubMed ID: 12209246
[TBL] [Abstract][Full Text] [Related]
58. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
[TBL] [Abstract][Full Text] [Related]
59. Clinicopathological characteristics and outcome indicators of stage II gastric cancer according to the Japanese classification of gastric cancer.
Ojima H; Araki K; Kato T; Okamura K; Manda R; Hirayama I; Hosouchi Y; Nishida Y; Kuwano H
Anticancer Res; 2006; 26(2B):1385-90. PubMed ID: 16619548
[TBL] [Abstract][Full Text] [Related]
60. Successful downstaging by S-1-based chemotherapy followed by surgical resections for gastric carcinoma with extensive distant lymph node metastasis - report of two cases and a review of cases with surgical resection after downstaging by S-1-based chemotherapy.
Yoshida I; Sakurai Y; Komori Y; Tonomura S; Masui T; Shoji M; Nakamura Y; Imazu H; Uyama I; Ochiai M
Hepatogastroenterology; 2005; 52(63):978-84. PubMed ID: 15966245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
